bioAffinity Technologies (BIAF) Operating Leases (2023 - 2025)
Historic Operating Leases for bioAffinity Technologies (BIAF) over the last 3 years, with Q3 2025 value amounting to $375139.0.
- bioAffinity Technologies' Operating Leases fell 2494.95% to $375139.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $375139.0, marking a year-over-year decrease of 2494.95%. This contributed to the annual value of $469596.0 for FY2024, which is 2432.75% up from last year.
- Per bioAffinity Technologies' latest filing, its Operating Leases stood at $375139.0 for Q3 2025, which was down 2494.95% from $407313.0 recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' Operating Leases ranged from a high of $499849.0 in Q3 2024 and a low of $331307.0 during Q2 2024
- Moreover, its 3-year median value for Operating Leases was $398260.0 (2023), whereas its average is $405852.3.
- In the last 5 years, bioAffinity Technologies' Operating Leases skyrocketed by 2550.82% in 2024 and then crashed by 2494.95% in 2025.
- bioAffinity Technologies' Operating Leases (Quarter) stood at $377709.0 in 2023, then grew by 24.33% to $469596.0 in 2024, then dropped by 20.11% to $375139.0 in 2025.
- Its Operating Leases stands at $375139.0 for Q3 2025, versus $407313.0 for Q2 2025 and $438757.0 for Q1 2025.